COLUMBUS NANOWORKS, INC. — Department of Health and Human Services SBIR Phase I: SBIR TOPIC: DEVELOPMENT OF DEVICES, DIAGNOSTIC TECHNOLOGIES, OR DIGITAL HEALTH TOOLS FOR T
COLUMBUS NANOWORKS, INC. — SBIR Phase I award from Department of Health and Human Services.
Phase I SBIR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Health and Human Services in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $506,498 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Quantum, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Columbus Nanoworks, Inc. received a $506,498 NIH SBIR Phase I award to evaluate quantum-based diagnostic tools for detecting inflammatory breast cancer. The project focuses on developing advanced devices or technologies for rare cancer diagnosis under a pediatric and rare cancers topic.
- Amount
- $506,498
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- OH
- Period
- 2025-09-05 → 2027-09-04
Technology domains
Description
SBIR TOPIC: DEVELOPMENT OF DEVICES, DIAGNOSTIC TECHNOLOGIES, OR DIGITAL HEALTH TOOLS FOR TREATMENT, DETECTION, AND DIAGNOSIS OF PEDIATRIC CANCERS AND/OR RARE CANCERS PHASE I CONCEPT TITLE: EVALUATING QUANTUM-BASED DIAGNOSTICS FOR INFLAMMATORY BREA